At a glance
ClinicalIndex Comparison RecordN/ACompleted· 543 enrolled
Drug / intervention
Juice Plus +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness of an Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms
In Brief
A clinical study evaluating Juice Plus and Placebo for Common Cold. Completed, enrolled 543 participants across 1 site.
Detailed Summary
The primary objective of this study is to determine the effect of an encapsulated juice powder concentrate on the number of days with at least moderate common cold symptoms over winter time.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommon Cold
CountriesGermany
CollaboratorsNSA, Collierville, TN, USA
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2008
First PostedOct 2008
Primary CompletionJul 2009
TodayJul 2026
First PostedOct 23, 2008
Enrollment StartSep 1, 2008
Primary CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.7 years ago
Interventions
Juice Plusdietary
Juice Plus+® is a dietary supplement from concentrated fruits (apple, orange, pineapple,cranberry, cherry (acerola), papaya and peach) and vegetables (carrot, parsley, beet, broccoli, kale, cabbage, spinach, and tomato). Subjects will take four capsules of Juice Plus+® daily.
Placebodietary
Four capsules of placebo daily.